Mar 31, 2025, 12:00 AM
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma
Background: Neoadjuvant immunotherapy has become the new standard of care for stage III melanoma. This study sought to describe the metabolic changes seen with fludeoxyglucose-18-positron emission to…
Circulating MicroRNAs: functional biomarkers for melanoma prognosis and treatment
MicroRNAs (miRNAs) hold significant promise as circulating cancer biomarkers and unlike many other molecular markers, they can provide valuable insights that extend beyond tumour biology. The expressi…
3D total-body photography in patients at high risk for melanoma: randomized clinical trial
Importance: Three-dimensional (3D) total-body photography (TBP) can support clinicians in monitoring and identifying changes to skin lesions in patients at high risk of melanoma. Objective: To as…
Cost-effectiveness analysis of 3D total-body photography for people at high risk of melanoma
Importance: Greater use of novel digital technologies could be associated with improved health outcomes and save health care costs by detecting smaller melanomas earlier (needing less treatment) or b…